Literature DB >> 28986705

Rescue therapy with alemtuzumab in multiple sclerosis post-natalizumab puerperium reactivation.

Jessica Frau1, Giancarlo Coghe2, Giuseppe Fenu2, Lorena Lorefice2, Eleonora Cocco2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28986705     DOI： 10.1007/s10072-017-3135-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  6 in total

1.  Natalizumab continuation during pregnancy in a patient with previous severe IRIS syndrome.

Authors:  M Théaudin; E Elefant; M V Senat
Journal:  J Neurol Sci       Date:  2015-10-28       Impact factor: 3.181

2.  Reassessing the risk of natalizumab-associated PML.

Authors:  Joseph R Berger; Robert J Fox
Journal:  J Neurovirol       Date:  2016-02-03       Impact factor: 2.643

3.  Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

Authors:  C Confavreux; M Hutchinson; M M Hours; P Cortinovis-Tourniaire; T Moreau
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

4.  Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse.

Authors:  Sandra Vukusic; Michael Hutchinson; Martine Hours; Thibault Moreau; Patricia Cortinovis-Tourniaire; Patrice Adeleine; Christian Confavreux
Journal:  Brain       Date:  2004-05-06       Impact factor: 13.501

5.  Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study.

Authors:  Susan Friend; Sandra Richman; Gary Bloomgren; Lynda M Cristiano; Madé Wenten
Journal:  BMC Neurol       Date:  2016-08-24       Impact factor: 2.474

Review 6.  Alemtuzumab for Multiple Sclerosis.

Authors:  Mark D Willis; Neil P Robertson
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081
  6 in total
  2 in total

1.  News on the journal Neurological Sciences in 2017.

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2018-01       Impact factor: 3.307

2.  Inflammasome Proteins As Biomarkers of Multiple Sclerosis.

Authors:  Robert W Keane; W Dalton Dietrich; Juan Pablo de Rivero Vaccari
Journal:  Front Neurol       Date:  2018-03-19       Impact factor: 4.003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.